In this TDO patient, DLX3 (Q178R) mutation results in lower levels of expression of RUNX2, OCN, ALP, BMP2, p16INK4a, p53, p21, and so on, decreases osteogenesis and senescence. This evidence concerns the gene CDKN2A and tricho-dento-osseous syndrome.